Health economic evaluation provides a comparison on the incremental costs between two interventions and whether this extra cost is justifiable by the incremental clinical benefits. It has been increasingly used by payers to inform drug reimbursement decision as it can answer the question on whether a new health technology will provide value-for-money. Consequently, alongside clinical […]
Read More